Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCAR2 | Q8TDS4 | 2/20 | 0.59 |
| ▸ | ESR1 | P03372 | 2/20 | 0.59 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.59 |
| ▸ | CA12 | O43570 | 1/20 | 0.59 |
| ▸ | AKR1B10 | O60218 | 1/20 | 0.59 |
| ▸ | CA1 | P00915 | 1/20 | 0.59 |
| ▸ | CA2 | P00918 | 1/20 | 0.59 |
| ▸ | CA3 | P07451 | 1/20 | 0.59 |
| ▸ | PKM | P14618 | 1/20 | 0.59 |
| ▸ | TYR | P14679 | 1/20 | 0.59 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.59 |
| ▸ | CA4 | P22748 | 1/20 | 0.59 |
| ▸ | CA6 | P23280 | 1/20 | 0.59 |
| ▸ | DPP4 | P27487 | 1/20 | 0.59 |
| ▸ | CA5A | P35218 | 1/20 | 0.59 |
| ▸ | CA7 | P43166 | 1/20 | 0.59 |
| ▸ | CA9 | Q16790 | 1/20 | 0.59 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.59 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.59 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL765933 | 1.00 | HCAR2 (0.59) | HCAR2ESR1ESR2CA12AKR1B10 | |
| Hydrochloric Acid SCHEMBL11763321 | 0.98 | HCAR2 (0.57) | HCAR2ESR1ESR2CA12AKR1B10 | |
| Bicarbonate SCHEMBL867321 | 0.98 | HCAR2 (0.57) | HCAR2ESR1ESR2CA12AKR1B10 | |
| SCHEMBL23512479 | 0.94 | KDM4E (0.57) | HCAR2ESR1ESR2CA12AKR1B10 | |
| SCHEMBL7957010 | 0.94 | KDM4E (0.57) | HCAR2ESR1ESR2CA12AKR1B10 | |
| SCHEMBL7957004 | 0.94 | KDM4E (0.57) | HCAR2ESR1ESR2CA12AKR1B10 | |
| Methacrylic Acid SCHEMBL10714814 | 0.90 | HCAR2 (0.49) | HCAR2ESR1ESR2CA12AKR1B10 | |
| SCHEMBL11283267 | 0.86 | F3 (0.57) | TYRKDM4EPTGS2SMN1; SMN2MAOB | |
| SCHEMBL11283271 | 0.86 | F3 (0.57) | TYRKDM4EPTGS2SMN1; SMN2MAOB | |
| SCHEMBL1206716 | 0.85 | KDM4E (0.67) | HCAR2ESR1ESR2CA12AKR1B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 308 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250352444-A1 | Antimicrobial mixtures | SYMRISE AG (DE) | 2025-11-20 | — | — | US | claimed |
| EP-4609167-A1 | COMPOSITION AND METHOD FOR CLEARING BIOLOGICAL SAMPLES | Centre National de la Recherche Scientifique (FR) | 2025-09-03 | — | — | EP | claimed |
| US-12365830-B2 | Ligand-exchangeable janus nanoparticles and methods of making the same | ALLIANCE FOR SUSTAINABLE ENERGY, LLC (US) | 2025-07-22 | — | — | US | claimed |
| EP-4525822-A1 | ANTIMICROBIAL MIXTURES | Symrise AG (DE) | 2025-03-26 | — | — | EP | claimed |
| WO-2024089224-A1 | COMPOSITION AND METHOD FOR CLEARING BIOLOGICAL SAMPLES | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2024-05-02 | — | — | WO | claimed |
| CN-117380269-B | Oil-soluble organic molybdenum catalyst and preparation method and application thereof | 北京高新利华科技股份有限公司 | 2024-04-05 | — | — | CN | claimed |
| CN-117380269-A | Oil-soluble organic molybdenum catalyst and preparation method and application thereof | 北京高新利华科技股份有限公司 | 2024-01-12 | — | — | CN | claimed |
| US-20230383163-A1 | COOLING LIQUID COMPOSITION FOR ELECTRIC VEHICLE | KD FINECHEM CO., LTD. (KR) | 2023-11-30 | — | — | US | claimed |
| WO-2023222577-A1 | ANTIMICROBIAL MIXTURES | SYMRISE AG (DE) | 2023-11-23 | — | — | WO | claimed |
| EP-4239033-A1 | COOLING LIQUID COMPOSITION FOR ELECTRIC VEHICLE | KD Finechem Co., Ltd. (KR) | 2023-09-06 | — | — | EP | claimed |
| US-9771552-B2 | Flavor system and method for making sherry wine like beverages | ALTRIA CLIENT SERVICES LLC (US) | 2017-09-26 | — | — | US | claimed |
| EP-3116328-B1 | FLAVOR SYSTEM AND METHOD FOR MAKING SHERRY WINE LIKE BEVERAGES | ALTRIA CLIENT SERVICES LLC (US) | 2017-08-09 | — | — | EP | claimed |
| EP-3116328-A1 | FLAVOR SYSTEM AND METHOD FOR MAKING SHERRY WINE LIKE BEVERAGES | Altria Client Services LLC (US) | 2017-01-18 | — | — | EP | claimed |
| US-20150259634-A1 | FLAVOR SYSTEM AND METHOD FOR MAKING SHERRY WINE LIKE BEVERAGES | Altria Client Services Inc. (US) | 2015-09-17 | — | — | US | claimed |
| WO-2015138742-A1 | FLAVOR SYSTEM AND METHOD FOR MAKING SHERRY WINE LIKE BEVERAGES | Altria Client Services Inc. (US) | 2015-09-17 | — | — | WO | claimed |
| US-20080131534-A1 | USE OF A PLANT EXTRACT OR PLANT JUICE | MELBROSIN INTERNATIONAL PRODUKTIONS- UND VERTRIEBS GESMBH & CO KG (AT) | 2008-06-05 | — | — | US | claimed |
| EP-1925311-A1 | Use of a plant extract or plant juice | Melbrosin International Produktions und Vertriebs GmbH & Co KG (AT) | 2008-05-28 | — | — | EP | claimed |
| US-5876492-A | Ink compositions containing esters | XEROX CORPORATION (US) | 1999-03-02 | — | — | US | claimed |
| EP-0319017-B1 | Treatment and after-treatment of metal with carbohydrate-modified polyphenol compounds | HENKEL CORP (US) | 1994-04-13 | — | — | EP | claimed |
| EP-0166542-A2 | Triterpenyl esters of organic acids, process for their production, and hypolipidemic agents composed of them | AMANO PHARMACEUTICAL CO., LTD. (JP) | 1986-01-02 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250352444-A1 | Antimicrobial mixtures | LRBA, MGLL, TAS2R50 | HCAR2 3860/4885ESR1 3680/4885ESR2 2608/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.